Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment


Phase 4 Results N/A

Trial Description

The primary objective is to compare the safety of clopidogrel 50mg and 75mg in cerebral infarction with respect to incidence of bleeding adverse events.



  • Clopidogrel (SR25990C) Drug
    Other Names: Plavix®
    Intervention Desc: oral administration
    ARM 1: Kind: Experimental
    Label: 1
    Description: 50 mg
    ARM 2: Kind: Experimental
    Label: 2
    Description: 75 mg

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Type Measure Time Frame Safety Issue
Primary Incidence of bleeding adverse events study period Yes
Secondary Incidence of Serious Adverse Events, serious bleeding events, adverse events. Incidence of vascular events. study period Yes